Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Jaspan

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology|October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsBirgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
Radiology|April 12, 2022
MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II TrialDaniel Rodriguez, Raphael Calmon, Esther Sanchez Aliaga, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology|October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsBirgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
Radiology|April 12, 2022
MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II TrialDaniel Rodriguez, Raphael Calmon, Esther Sanchez Aliaga, et al.
Pageof 2